Philip Cavanaugh
3Patents
1h-index
1Co-inventors
34Inventor score
Filing activity: May 23, 1988 → Dec 5, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5393534A | Liver-derived tumor cell growth inhibitor | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7582443B2 | Method for the detection and measurement of Hapten-conjugated biological binding entities by western and dot-blot using anti-hapten antibodies | Emerging Cross-Sectional Technologies | 0 | Expired |
| US5164489A | Lung growth stimulatory and inhibitory factors for carcinoma tumor cells | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.